Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Durant

Showing results (121-130 of 234) with videos related to

Pageof 24
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1984
Vitrectomy and Whipple's diseaseW J Durant, T Flood, M F Goldberg, et al.
Annales De Pathologie|January 1, 1995
[Muscular involvement in the course of AIDS. Anatomo-clinical study of 17 cases]C Butori, C Desnuelle, P Hofman, et al.
Drugs|January 1, 1995
Effect of subinhibitory concentrations of pefloxacin in infection in mice due to susceptible or resistant strainsH Carsenti-Etesse, M Bensoussan, F Bensoussan, et al.
The Journal of Eukaryotic Microbiology|March 21, 1998
In vitro and in vivo models of Pneumocystis cariniiM S Bartlett, S F Queener, M M Shaw, et al.
Nature|November 23, 1978
Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptorsG J Durant, W A Duncan, C R Ganellin, et al.
Cancer|May 15, 1990
Breakout I. Ethical considerationsR J McKenna, J Laszlo, J Durant, et al.
Cancer|December 1, 1984
Combination chemotherapy in small cell lung carcinoma. A randomized study of two intensive regimensS Lowenbraun, R Birch, R Buchanan, et al.
British Journal of Pharmacology|March 1, 1975
The pharmacology of cimetidine, a new histamine H2-receptor antagonistR W Brimblecombe, W A Duncan, G J Durant, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1995
In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniaeH Carsenti-Etesse, J Durant, F De Salvador, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 1, 1995
In vitro development of resistance of Streptococcus pneumoniae to beta-lactam antibioticsH Carsenti-Etesse, J Durant, F De Salvador, et al.
Pageof 24

Showing results (121-130 of 234) with videos related to

Sort By:
Pageof 24
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1984
Vitrectomy and Whipple's diseaseW J Durant, T Flood, M F Goldberg, et al.
Annales De Pathologie|January 1, 1995
[Muscular involvement in the course of AIDS. Anatomo-clinical study of 17 cases]C Butori, C Desnuelle, P Hofman, et al.
Drugs|January 1, 1995
Effect of subinhibitory concentrations of pefloxacin in infection in mice due to susceptible or resistant strainsH Carsenti-Etesse, M Bensoussan, F Bensoussan, et al.
The Journal of Eukaryotic Microbiology|March 21, 1998
In vitro and in vivo models of Pneumocystis cariniiM S Bartlett, S F Queener, M M Shaw, et al.
Nature|November 23, 1978
Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptorsG J Durant, W A Duncan, C R Ganellin, et al.
Cancer|May 15, 1990
Breakout I. Ethical considerationsR J McKenna, J Laszlo, J Durant, et al.
Cancer|December 1, 1984
Combination chemotherapy in small cell lung carcinoma. A randomized study of two intensive regimensS Lowenbraun, R Birch, R Buchanan, et al.
British Journal of Pharmacology|March 1, 1975
The pharmacology of cimetidine, a new histamine H2-receptor antagonistR W Brimblecombe, W A Duncan, G J Durant, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1995
In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniaeH Carsenti-Etesse, J Durant, F De Salvador, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 1, 1995
In vitro development of resistance of Streptococcus pneumoniae to beta-lactam antibioticsH Carsenti-Etesse, J Durant, F De Salvador, et al.
Pageof 24